Charlotte, NC, United States of America

Jean-Luc C Mougeot


Average Co-Inventor Count = 2.3

ph-index = 1

Forward Citations = 2(Granted Patents)


Company Filing History:


Years Active: 2018-2021

Loading Chart...
3 patents (USPTO):Explore Patents

Title: The Innovative Contributions of Jean-Luc C Mougeot

Introduction

Jean-Luc C Mougeot is a notable inventor based in Charlotte, NC (US). He has made significant contributions to the field of oral health, particularly in relation to cancer therapy. With a total of 3 patents, his work focuses on understanding and improving the oral microbiome and its implications for patients undergoing cancer treatment.

Latest Patents

Mougeot's latest patents include innovative methods and compositions that address critical issues in oral health. One of his patents, titled "Compositions and methods for oral microbiome signatures," provides methods and compositions involving microbiome signatures and their association with oral complications of cancer therapy. Another significant patent is "Compositions and methods for genetic markers to identify risk of oral mucositis," which offers methods and compositions involving genetic markers and their association with oral mucositis occurring in patients treated with cancer therapy and/or conditioning therapy for hematopoietic stem cell transplantation.

Career Highlights

Jean-Luc C Mougeot is affiliated with the Charlotte-Mecklenburg Hospital Authority, where he applies his expertise in oral health and microbiome research. His work is instrumental in advancing the understanding of oral complications faced by cancer patients, thereby improving their quality of care.

Collaborations

Mougeot collaborates with esteemed colleagues, including Farah K B Mougeot and Nirav Shah, to further enhance research and innovation in the field of oral health.

Conclusion

Jean-Luc C Mougeot's contributions to oral health through his innovative patents and collaborative efforts highlight the importance of research in improving patient outcomes. His work continues to pave the way for advancements in the understanding of oral complications related to cancer therapy.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…